glp 1 rheumatoid arthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? I want to talk about

Namkung J, Kim H, Park S

In the SURMOUNT-5 head-to-head trial against semaglutide, tirzepatide at maximum dose produced 20.2% weight loss compared to semaglutide at 13.7%

GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study

Since then, the class has quickly grown to include albiglutide, dulaglutide, liraglutide, lixisenatide, and semaglutide

As GLP-1s gain approvals for additional disease areas - Novo is studying semaglutide in addiction, osteoarthritis, and MASHthe companies continue extending patent protection through method-of-use claims that could sustain market exclusivity well beyond initial compound patents [40]

The supplement approach operates on an entirely different speed scale